tirzepatide fda obesity (AKA Mounjaro and Zepbound) approved for weight loss! #tirzepatide #tirzepatideweightloss #mounjaro #zepbound #fdaapproved #fdaapproval #mounjaroupdate #tirzepatideprice #weightloss Many US patients opt for

Emerging research suggests that by improving metabolic health and promoting significant weight loss, Semaglutide may help lower the risk of certain obesity-related cancers, including colorectal and breast cancer

In 2023 the FDA updated the requirements for some GLP1 drugs to include a warning for ileus, intestinal blockage, a rare, but potentially-fatal complication

With the right balance of medication, nutrition and lifestyle guidance, most people adapt well, and continue to enjoy food in a way that feels satisfying," she concludes

Tilt your head forward slightly

Many people begin to notice increased energy and mental sharpness within hours or days